Dupilumab on Airway Hyper-responsiveness and Ventilation Heterogeneity in Patients With Asthma.

NCT03884842 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Asthma

Interventions

BIOLOGICAL: Dupilumab/Dupixent
BIOLOGICAL: Placebo

Sponsor

McMaster University

Collaborators

[object Object]